| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Paediatric Endocrinology and Metabolism (M.A.S., J.P.H.S., E.C.C.), Institute of Child Health, Royal Hospital for Children, Bristol BS2 8AE, United Kingdom; Clinical Sciences South Bristol (J.M.P.H., S.J.T., M.J.G.), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom; and Department of Exercise and Sport Science (C.E.H.S.), Manchester Metropolitan University Cheshire (Alsager Campus), Alsager ST7 2HL, United Kingdom
Address all correspondence and requests for reprints to: Dr. M. A. Sabin, Diabetes UK Clinical Training Fellow, Department of Pediatric Endocrinology and Metabolism, Institute of Child Health, Royal Hospital for Children, Upper Maudlin Street, Bristol BS2 8AE, United Kingdom. E-mail: mattsabin{at}doctors.org.uk.
| Abstract |
|---|
|
|
|---|
Patients: Paired subcutaneous (Sc) and visceral (V) fat samples were obtained from 12 normal-weight children.
Main Outcome Measures: Mature adipocytes were isolated and total adiponectin levels determined by ELISA. Insulin sensitivity and lipid parameters were assessed in fasting blood samples taken at the time of biopsy collection.
Results: A positive correlation was seen between the adiponectin concentration within the Sc and V mature adipocytes derived from each child (r = 0.924; P < 0.001). After logarithmic transformation of the Sc and V adiponectin concentrations (log-Sc and log-V) to render the data Gaussian, both log-Sc and log-V were found to be lower in those children with higher body mass index SD score (r = 0.621 and r = 0.357 respectively), although this reached statistical significance only in the Sc adipocytes (P = 0.03). Age was not related to either log-Sc or log-V adiponectin levels, although a significant negative association was seen with serum adiponectin (r = 0.589; P = 0.04). Log-Sc or log-V did not correlate with serum adiponectin concentrations, markers of insulin sensitivity, or circulating lipid levels.
Conclusions: These data indicate a relationship between total adiponectin levels in different tissue compartments, suggesting either some form of interaction or coregulation by systemic factors, possibly related to body size/fat mass. Serum concentrations of total adiponectin were inversely related to age but showed no relationship with either tissue levels or body mass index SD score.
| Introduction |
|---|
|
|
|---|
Adiponectin is thought to increase insulin sensitivity predominantly by an increase in fatty acid oxidation (by activation of AMP kinase) and inhibition of hepatic glucose production (2). However, although adiponectin levels are decreased in viscerally obese adults and children, the relationship between adiponectin protein expression in mature subcutaneous (Sc) and visceral (V) adipocytes in children has not been previously explored. Several studies have assessed adiponectin mRNA expression in adult human Sc and V fat samples, and these have found either no difference between the two compartments (6) or lower levels in the V adipocytes compared with the Sc (7, 8, 9). Interestingly, one of these studies also found a significant correlation between paired Sc and V adiponectin mRNA levels (6). Furthermore, in studies assessing mRNA expression in Sc and V adipocytes derived from adults over a wide body mass index (BMI) range, Sc levels appeared to decrease with increasing BMI, whereas V levels did not appear to change (10). We therefore sought to examine the adiponectin levels in paired Sc and V fat samples obtained from 12 normal-weight children to investigate whether there are inherent differences in adiponectin levels in different fat compartments from an early age as opposed to these differences developing in later life because of exposure to environmental factors or the differential accumulation of fat stores. Furthermore, we aimed to examine whether adiponectin protein levels in paired Sc and V fat samples were related to each other and whether they correlated with circulating adiponectin concentrations, homeostasis model assessment for insulin resistance (HOMA-R, a marker of peripheral insulin resistance) (11), circulating lipids, and/or the BMI SD score (SDS), which corrects the BMI for the age and sex of the child (12).
| Subjects and Methods |
|---|
|
|
|---|
0.20.5 g) of Sc and intraabdominal V fat were obtained. The fat samples were obtained by experienced pediatric surgeons with the Sc samples coming from directly under the skin and the V samples from fat located adjacent to the intraabdominal organs. Twelve paired biopsies (seven male) yielded sufficient mature adipocytes to analyze adiponectin levels. The median age (range) was 5.7 (1.19.9) yr, and the mean (range) BMI and BMI SDS were 17.2 (14.322.2) kg/m2 and 0.55 (1.64 to 2.13), respectively. Clinical details are shown in Table 1
|
The biopsies were transported to the laboratory in sterile pots and the mature adipocytes isolated using a previously described method developed within our laboratory (14). Briefly, the adipose tissue was washed three times in Hanks balanced salt solution, cut into 1-mm3 pieces, and digested with 10 ml of 1 mg/ml type II collagenase in Hanks balanced salt solution for 60 min at 37 C. The mature adipocytes were separated from the stromal fraction by centrifugation at 80 x g for 3 min and were carefully removed to a sterile Eppendorf containing a matched packed cell volume of lysis buffer (10 mM Tris-Cl, 50 mM sodium chloride, 5 mM EDTA, 15 mM sodium pyrophosphate, 50 mM sodium fluoride, 100 µM sodium orthovanadate, and 1% Triton X-100 with freshly added 1% phenylmethylsulfonyl fluoride at the time of use). The mature adipocytes were lysed via repeated passaging through a 21-gauge needle and the lysates frozen at 20 C. Samples were batch processed, and adiponectin concentrations were determined using standard ELISA kits from Metachem Diagnostics, Inc. (Piddington Northampton, UK) (minimum detectable limit, 23.4 pg/ml). Each assay was performed in accordance with the manufacturers instructions, and adiponectin concentrations were related to the total protein in each sample (Pierce BCA protein assay; Pierce Biotechnology, Rockford, IL).
The fasting blood samples were analyzed for 1) adiponectin concentrations using the adiponectin ELISA kit by Metachem Diagnostics [intraassay coefficient of variation (CV), 4.3%; interassay CV 5.3%], 2) insulin using an ELISA method (DakoCytomation, Glostrup, Denmark; code no. K6219; intraassay CV, 2.0%; interassay CV, 3.9%; minimum detectable limit, 1 mIU/liter), 3) glucose using a standard hexokinase assay on an Olympus (Mellville, NY) automated analyzer, and 4) a standard lipid profile (cholesterol, high- and low-density lipoproteins, and triglyceride levels) using an Olympus Diagnostics System Group assay. HOMA-R was calculated as (insulin x glucose/22.5), as previously described (11).
Statistical analyses were by Students paired t test and Pearsons correlation coefficient, with a P value < 0.05 being considered statistically significant.
| Results |
|---|
|
|
|---|
The adiponectin concentration within the mature Sc adipocyte lysates was positively associated with the paired V adiponectin concentration derived from each child (r = 0.924; P < 0.001) as shown in Fig. 1A
. Overall within this group, there was no significant difference in the mean adiponectin concentration between the Sc and V mature adipocytes (mean ± SD was 238 ± 190 for Sc vs. 247 ± 177 ng/mg protein for V; P = 0.69).
|
Both log-Sc and log-V were found to be lower in those children with higher BMI SDS (r = 0.621 and r = 0.357, respectively), although this reached statistical significance only in the Sc adipocytes (P = 0.03), as demonstrated in Fig. 1B
.
No correlation was seen between the log-Sc or log-V values and the serum adiponectin level, lipid profile, fasting insulin, or HOMA-R after adjustment for age and sex. Likewise, no correlation was found between age-adjusted serum adiponectin levels and fasting insulin, HOMA-R, or components of a standard lipid profile (total cholesterol, high-density and low-density lipoproteins, and triglycerides).
| Discussion |
|---|
|
|
|---|
Despite finding that increased age was associated with lower serum adiponectin concentrations, we were unable to show any significant age effect on adipose tissue adiponectin levels. Furthermore, we were unable to demonstrate any correlation between log-Sc or log-V adiponectin concentrations with corresponding serum adiponectin levels. These findings suggest that factors other than adipose tissue content, such as synthesis, secretion, clearance, and storage may be important in determining serum adiponectin concentrations. The current development of specific assays for HMW and LMW adiponectin may help to clarify the lack of concordance between tissue and serum total adiponectin levels.
Furthermore, we found that fat samples taken from children with higher BMI SDS, even within the nonobese range, had lower levels of adiponectin in both the Sc and V adipocytes compared with their leaner counterparts, although this negative correlation was significant only in the Sc adipocytes. This suggests that increasing BMI SDS in childhood is associated with reductions in Sc adiponectin content. This would be consistent with the findings in adults where adiponectin mRNA (10) and protein levels (8) were found to be lower in the Sc adipocytes derived from individuals with higher BMI. Furthermore, and in agreement with the findings from the former study, we were unable to show a significant decrease in V adiponectin concentrations with increasing BMI. However, it is unclear in the latter study whether the omission of any changes in omental adipocyte adiponectin concentrations with BMI was because of an absence of any significant differences or simply a lack of omental samples from their obese patients.
No correlation was observed between the serum adiponectin concentration and BMI SDS, fasting insulin, or HOMA-R in this group. Although previous studies have reported such associations, they have always incorporated a broader spectrum of clinical phenotypes in larger numbers of subjects. Similarly, we were unable to demonstrate any correlation between log-Sc and log-V levels with fasting insulin or HOMA-R, and (in 11 of the 12 children where fasting bloods were also analyzed for a standard lipid profile) there was no correlation with fasting lipids.
Very few children have routine operations for nonmalignant, nonseptic conditions, and therefore obtaining paired Sc and V adipocytes for this study proved difficult, limiting our sample size. Despite this constraint, we feel that our data raise some interesting points that require additional study. First, the significant association between the adiponectin levels within the Sc and V fat compartments suggests that, even in young children, a degree of interaction or coregulation of adiponectin tissue levels is present. Second, we have demonstrated that although serum adiponectin levels appear to decrease with increasing age, adiponectin levels within adipocytes appear to be more dependent upon an individuals BMI SDS, especially within Sc fat tissue and even within a normal BMI range. The reasons for this are currently unclear. Third, we were unable to find any correlation between circulating adiponectin concentrations and tissue adiponectin levels in either the Sc or V fat samples, again suggesting that regulation of serum adiponectin levels is not solely dependent on adipose tissue levels. Additional work in this area is required if we are to fully understand the reasons for hypoadiponectinemia in viscerally obese individuals.
| Acknowledgments |
|---|
| Footnotes |
|---|
First Published Online October 25, 2005
1 C.E.H.S. and E.C.C. contributed equally to this work. ![]()
Abbreviations: BMI, Body mass index; HOMA-R, homeostasis model assessment for insulin resistance; HMW, high molecular weight; LMW, low molecular weight; Sc, subcutaneous; SDS, SD score; V, visceral.
Received July 14, 2005.
Accepted October 14, 2005.
| References |
|---|
|
|
|---|
. Obes Res 13:662669[Medline]
and IGF-I. J Lipid Res 46:93103This article has been cited by other articles:
![]() |
M. A. Sabin, M. De Hora, J. M.P. Holly, L. P. Hunt, A. L. Ford, S. R. Williams, J. S. Baker, C. J. Retallick, E. C. Crowne, and J. P.H. Shield Fasting Nonesterified Fatty Acid Profiles in Childhood and Their Relationship With Adiposity, Insulin Sensitivity, and Lipid Levels Pediatrics, December 1, 2007; 120(6): e1426 - e1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pagano and D. D. Gutterman The adventitia: The outs and ins of vascular disease Cardiovasc Res, September 1, 2007; 75(4): 636 - 639. [Full Text] [PDF] |
||||
![]() |
G. Fesus, G. Dubrovska, K. Gorzelniak, R. Kluge, Y. Huang, F. C. Luft, and M. Gollasch Adiponectin is a novel humoral vasodilator Cardiovasc Res, September 1, 2007; 75(4): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |